| Beskrivelse: | Amplikon baseret targeteret NGS med S5 Ion Torrent teknologien. Panel: Expanded Oncomine Myeloid Research Assay. NGS analysen dækker omkring 99% af følgende genområder: ABL1 (exon 4-9), ANKRD26 (exon 1, 27), ASXL1, BCOR, BCORL1, BRAF (exon 1-4, 6, 8, 11, 15, 17-18), CALR, CBL (exon 8-9), CEBPA, CSF3R (exon 10, 14, 17), DDX41, DNMT3A (exon 11-23), ETNK1 (exon 3), ETV6, EZH2, FLT3 (exon 8, 11, 13-16, 20, 23-24), GATA1 (exon 2, 4), GATA2 (exon 4-5), HRAS (exon 2-3), IDH1 (exon 4), IDH2 (exon 4), IKZF1, JAK2 (exon 12-15), KIT (exon 1-2, 8-11, 13, 17), KRAS (exon 2-6), MPL (exon 3-4, 10, 12), MYD88 (exon 3, 5), NF1, NPM1 (exon 11), NRAS (exon 2-4), PHF6, PPM1D (exon 6),PRPF8, PTPN11 (exon 3, 4, 12, 13), RAD21, RB1, RUNX1, SETBP1 (exon 6), SF3B1 (exon 14-21), SMC1A (exon 2, 11, dele af exon 4 og 5), SMC3 (exon 13, 19), SH2B3, SRSF2 (exon 1), STAG2, STAT3 (exon 20-21), STAT5B (exon 16-19), TET2, TP53, UBA1 (exon 3), U2AF1 (exon 2, 7), WT1 (exon 7, 9) og ZRSR2. |